To understand whether these and other inflammatory pathways are dysregulated in Nlrp12–/– colorectal tumors, we measured the activation of NF-κB, ERK, JNK, STAT3, and AKT in tumors collected on day 80 after AOM/DSS treatment. This evidence concerns the gene NFKB1 and colorectal neoplasm.